A Multi-Center, Open-Label, Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens

Trial Profile

A Multi-Center, Open-Label, Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Fluorouracil; Folitixorin
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors Mast Therapeutics
  • Most Recent Events

    • 12 Mar 2008 Results will be presented at the 2008 American Society of Clinical Oncology (ASCO) annual meeting on 2 June.
    • 07 Dec 2007 Results are expected during the second quarter of 2008.
    • 05 Dec 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top